FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

4 letters match. Newest first.

  1. Purushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital

    FDA warned Senthil Specialty Hospital and Dr. Purushothaman Damodara Kumaran about missed safety monitoring in a bioequivalence study of an investigational drug.

    High risk
  2. Amy Lightner, MD

    FDA warns sponsor-investigator Amy Lightner, MD over clinical trial violations, including dosing before eligibility tests and unreported serious adverse events.

    High risk
  3. Sol-ti Inc.

    FDA found Sol-ti's ready-to-drink juices lacked validated pathogen controls and required safety monitoring.

    High risk
  4. Joseph A. Zadra, M.D.

    FDA warned clinical investigator Dr. Zadra for enrolling an ineligible subject and skipping required safety labs in a drug study.

    High risk